Main Menu
No results found.
Here are some suggested resources.
Case Studies
October 23, 2024
The Drugs for Neglected Diseases Initiative (DNDi), an international non-profit, discovers, develops, and delivers treatments to save lives and improve the health of people living with neglected diseases. The organization fosters collaboration…
Case Studies
April 25, 2024
Tuberculosis (TB) is the 13th leading cause of death globally, even though it is both preventable and curable. According to the World Health Organization, an...
Case Studies
December 8, 2023
When DNDi was ready to share the results of a clinical study comparing treatments for people living with HIV who had leishmaniasis, they turned to...
Case Studies
November 9, 2023
A global pharma company received FDA approval for a drug to treat a chronic disease. With uptake falling short of expectations, the client wanted to publish...
Videos
July 10, 2023
Privacy Analytics’ flexible, extensible platform – with technology and commercial software options – enables you to put your sensitive data to work.
Webinars
Date of Webinar: June 1, 2023
June 8, 2023
On May 16, the European Medicines Agency (EMA) confirmed that after a long hiatus (punctuated only by COVID-related publications), Policy 0070 will officially resume in September 2023. Join Niamh McGuinness, Senior Advisor, Clinical Trial Transparency and Privacy, to learn the key points of EMA's announcement.